Product information

Current status:

Cancelled Post Market

Current status date:

2013-08-02

Original market date: ^{See footnote 1}

2001-04-10

Product name:

APO-MIDAZOLAM INJECTABLE 5 MG/ML

DIN:

02243254 Electronic product monograph is not available

Company:

APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada M9L 1T9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05CD08 MIDAZOLAM

Active ingredient group (AIG) number:^{See footnote5}

0119935001